3593
HOGY MEDICAL CO.,LTD.
株式会社ホギメディカルHogy Medical Co.,Ltd., together with its subsidiaries, engages in the manufacture and sale of medical consumables, medical equipment, and medical nonwoven products in Japan. The company offers surgical kit products; sterilization products comprising Mekkin bags sterilization pouches and sterilization containers; non-woven fabric products; remanufactured single-use devices; operation support related, such as operating room management services, OPENO, case studies services, and OPERA-Compass and narcotics and poisons box. It also provides minimally invasive treatment products, including SuReFInD for assistance in the excision of small-cell lung cancer in pneumonectomy operations; EMARO, an endoscope holder; SECUREA, a sponge for endoscopic surgery; and personal protective equipment related products. The company was formerly known as Hogy Co., Ltd. and changed its name to Hogy Medical Co.,Ltd. in 1987. Hogy Medical Co.,Ltd. was incorporated in 1961 and is headquartered in Tokyo, Japan. As of March 2, 2026, Hogy Medical Co.,Ltd. operates as subsidiary of The Carlyle Group Inc.
Price
¥6,660
Market Cap
¥143.6B
Ent. Value
¥135.3B
Net Cash
¥8.3B
Shares Out.
21.6M
P / E
98.0×
EV / EBIT
35.5×
P / Book
1.93×
P / NCAV
6.96×
Div. Yield
1.20%
Financials
| Metric |
FY 2024
EDINET ↗ |
FY 2023
EDINET ↗ |
FY 2022
EDINET ↗ |
FY 2021
EDINET ↗ |
|---|---|---|---|---|
| Net Sales | ¥39.1B | ¥39.1B | ¥39.0B | ¥36.8B |
| Cost of Sales | ¥26.5B | ¥26.0B | ¥23.2B | ¥21.4B |
| Gross Profit | ¥12.6B | ¥13.1B | ¥15.7B | ¥15.4B |
| SG&A | ¥8.8B | ¥8.9B | ¥9.1B | ¥9.3B |
| Operating Income | ¥3.8B | ¥4.2B | ¥6.6B | ¥6.1B |
| Non-Operating Income | ¥457M | ¥440M | ¥261M | ¥406M |
| Dividend Income | ¥71M | ¥58M | ¥49M | ¥45M |
| Interest Income | ¥214M | ¥249M | ¥106M | ¥39M |
| Non-Operating Expenses | ¥622M | ¥363M | ¥242M | ¥255M |
| Interest Expense | ¥70M | ¥23M | ¥29M | ¥6M |
| Ordinary Income | ¥3.6B | ¥4.2B | ¥6.7B | ¥6.3B |
| Pre-tax Income | ¥2.9B | ¥4.1B | ¥6.2B | ¥6.3B |
| Income Taxes | ¥1.4B | ¥1.3B | ¥1.9B | ¥2.0B |
| Current Tax | ¥1.6B | ¥1.2B | ¥2.2B | ¥2.0B |
| Deferred Tax | ¥-209M | ¥99M | ¥-272M | ¥0M |
| Net Income (owners) | ¥1.5B | ¥2.8B | ¥4.3B | ¥4.4B |
| Minority Interest | ¥0M | ¥-11M | ¥-31M | ¥-35M |
| Comprehensive Income | ¥1.6B | ¥4.3B | ¥5.4B | ¥4.7B |
| EBITDA | ¥9.6B | ¥10.8B | ¥10.3B | ¥10.2B |
| EPS | ¥67.98 | ¥115.57 | ¥177.95 | ¥153.00 |
| Shares Outstanding | 21.6M | 24.3M | 24.3M | 24.3M |
| Shares Issued (total) | 22.5M | 25.3M | 32.7M | 32.7M |
| Treasury Shares | 1.0M | 1.0M | 8.4M | 8.4M |